Hyoscine - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509241218

Publication Date:

September 19, 2024

Pages:

124

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Hyoscine, also referred as scopolamine, is utilized as a medicine to treat motion sickness, gastrointestinal spasms, vomiting, and postoperative nausea. In addition, it is utilized sometimes before surgery to decrease saliva. Hyoscine belongs to antimuscarinic family and works by blocking some acetylcholine effects within the nervous system.
The global market for Hyoscine was estimated to be worth US$ 442.6 million in 2023 and is forecast to a readjusted size of US$ 617.1 million by 2030 with a CAGR of 4.8% during the forecast period 2024-2030
The increased incidence of motion sicknesses such as nausea and vomiting further led to the adoption of hyoscine medicines. Additionally, the market's growth is aided by increased research in the field of Hyoscine. For instance, an article published on April 2022 by BMC Journal showed that pre-treatment with intravenous hyoscine butyl-bromide (HBB) is a risk-free method for both the mother and the child in cesarean section patients undergoing spinal anesthesia to lower the risk of severe intraoperative bradycardia. Furthermore, the increase in travel worldwide is likely to boost the hyoscine market since motion sickness is mainly treated with hyoscine. For instance, as per the June 2022 report from UNWTO, the latest World Tourism Barometer showed an increase of 182% for international tourism in the first three months of 2022 compared to the previous year.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hyoscine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Hyoscine by region & country, by Type, and by Application.
The Hyoscine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyoscine.
麻豆原创 Segmentation
By Company
Alchem International Ltd.
Alkaloids Corporation
Baxter International Inc.
Caleb Pharmaceuticals, Inc.
Centroflora Cms S. R.L.
GlaxoSmithKline Plc
Guangzhou Hanfang Pharmaceutical Co., Ltd.
Myungmoon Pharma Co., Ltd.
Novartis International AG
Perrigo Company Plc
Boehringer-Ingelheim
Linnea
C2 PHARMA
Segment by Type:
Hyoscine Butylbromide
Hyoscine Hydrobromide
Segment by Application
Oral
Injections
Patches
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Hyoscine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Hyoscine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Hyoscine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Hyoscine Product Introduction
1.2 Global Hyoscine 麻豆原创 Size Forecast
1.2.1 Global Hyoscine Sales Value (2019-2030)
1.2.2 Global Hyoscine Sales Volume (2019-2030)
1.2.3 Global Hyoscine Sales Price (2019-2030)
1.3 Hyoscine 麻豆原创 Trends & Drivers
1.3.1 Hyoscine Industry Trends
1.3.2 Hyoscine 麻豆原创 Drivers & Opportunity
1.3.3 Hyoscine 麻豆原创 Challenges
1.3.4 Hyoscine 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hyoscine Players Revenue Ranking (2023)
2.2 Global Hyoscine Revenue by Company (2019-2024)
2.3 Global Hyoscine Players Sales Volume Ranking (2023)
2.4 Global Hyoscine Sales Volume by Company Players (2019-2024)
2.5 Global Hyoscine Average Price by Company (2019-2024)
2.6 Key Manufacturers Hyoscine Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Hyoscine Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Hyoscine
2.9 Hyoscine 麻豆原创 Competitive Analysis
2.9.1 Hyoscine 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Hyoscine Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyoscine as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hyoscine Butylbromide
3.1.2 Hyoscine Hydrobromide
3.2 Global Hyoscine Sales Value by Type
3.2.1 Global Hyoscine Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Hyoscine Sales Value, by Type (2019-2030)
3.2.3 Global Hyoscine Sales Value, by Type (%) (2019-2030)
3.3 Global Hyoscine Sales Volume by Type
3.3.1 Global Hyoscine Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Hyoscine Sales Volume, by Type (2019-2030)
3.3.3 Global Hyoscine Sales Volume, by Type (%) (2019-2030)
3.4 Global Hyoscine Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oral
4.1.2 Injections
4.1.3 Patches
4.2 Global Hyoscine Sales Value by Application
4.2.1 Global Hyoscine Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Hyoscine Sales Value, by Application (2019-2030)
4.2.3 Global Hyoscine Sales Value, by Application (%) (2019-2030)
4.3 Global Hyoscine Sales Volume by Application
4.3.1 Global Hyoscine Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Hyoscine Sales Volume, by Application (2019-2030)
4.3.3 Global Hyoscine Sales Volume, by Application (%) (2019-2030)
4.4 Global Hyoscine Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Hyoscine Sales Value by Region
5.1.1 Global Hyoscine Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Hyoscine Sales Value by Region (2019-2024)
5.1.3 Global Hyoscine Sales Value by Region (2025-2030)
5.1.4 Global Hyoscine Sales Value by Region (%), (2019-2030)
5.2 Global Hyoscine Sales Volume by Region
5.2.1 Global Hyoscine Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Hyoscine Sales Volume by Region (2019-2024)
5.2.3 Global Hyoscine Sales Volume by Region (2025-2030)
5.2.4 Global Hyoscine Sales Volume by Region (%), (2019-2030)
5.3 Global Hyoscine Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Hyoscine Sales Value, 2019-2030
5.4.2 North America Hyoscine Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Hyoscine Sales Value, 2019-2030
5.5.2 Europe Hyoscine Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Hyoscine Sales Value, 2019-2030
5.6.2 Asia Pacific Hyoscine Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Hyoscine Sales Value, 2019-2030
5.7.2 South America Hyoscine Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hyoscine Sales Value, 2019-2030
5.8.2 Middle East & Africa Hyoscine Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hyoscine Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Hyoscine Sales Value
6.2.1 Key Countries/Regions Hyoscine Sales Value, 2019-2030
6.2.2 Key Countries/Regions Hyoscine Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Hyoscine Sales Value, 2019-2030
6.3.2 United States Hyoscine Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Hyoscine Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Hyoscine Sales Value, 2019-2030
6.4.2 Europe Hyoscine Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Hyoscine Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Hyoscine Sales Value, 2019-2030
6.5.2 China Hyoscine Sales Value by Type (%), 2023 VS 2030
6.5.3 China Hyoscine Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Hyoscine Sales Value, 2019-2030
6.6.2 Japan Hyoscine Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Hyoscine Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Hyoscine Sales Value, 2019-2030
6.7.2 South Korea Hyoscine Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Hyoscine Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Hyoscine Sales Value, 2019-2030
6.8.2 Southeast Asia Hyoscine Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Hyoscine Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Hyoscine Sales Value, 2019-2030
6.9.2 India Hyoscine Sales Value by Type (%), 2023 VS 2030
6.9.3 India Hyoscine Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Alchem International Ltd.
7.1.1 Alchem International Ltd. Company Information
7.1.2 Alchem International Ltd. Introduction and Business Overview
7.1.3 Alchem International Ltd. Hyoscine Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Alchem International Ltd. Hyoscine Product Offerings
7.1.5 Alchem International Ltd. Recent Development
7.2 Alkaloids Corporation
7.2.1 Alkaloids Corporation Company Information
7.2.2 Alkaloids Corporation Introduction and Business Overview
7.2.3 Alkaloids Corporation Hyoscine Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Alkaloids Corporation Hyoscine Product Offerings
7.2.5 Alkaloids Corporation Recent Development
7.3 Baxter International Inc.
7.3.1 Baxter International Inc. Company Information
7.3.2 Baxter International Inc. Introduction and Business Overview
7.3.3 Baxter International Inc. Hyoscine Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Baxter International Inc. Hyoscine Product Offerings
7.3.5 Baxter International Inc. Recent Development
7.4 Caleb Pharmaceuticals, Inc.
7.4.1 Caleb Pharmaceuticals, Inc. Company Information
7.4.2 Caleb Pharmaceuticals, Inc. Introduction and Business Overview
7.4.3 Caleb Pharmaceuticals, Inc. Hyoscine Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Caleb Pharmaceuticals, Inc. Hyoscine Product Offerings
7.4.5 Caleb Pharmaceuticals, Inc. Recent Development
7.5 Centroflora Cms S. R.L.
7.5.1 Centroflora Cms S. R.L. Company Information
7.5.2 Centroflora Cms S. R.L. Introduction and Business Overview
7.5.3 Centroflora Cms S. R.L. Hyoscine Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Centroflora Cms S. R.L. Hyoscine Product Offerings
7.5.5 Centroflora Cms S. R.L. Recent Development
7.6 GlaxoSmithKline Plc
7.6.1 GlaxoSmithKline Plc Company Information
7.6.2 GlaxoSmithKline Plc Introduction and Business Overview
7.6.3 GlaxoSmithKline Plc Hyoscine Sales, Revenue and Gross Margin (2019-2024)
7.6.4 GlaxoSmithKline Plc Hyoscine Product Offerings
7.6.5 GlaxoSmithKline Plc Recent Development
7.7 Guangzhou Hanfang Pharmaceutical Co., Ltd.
7.7.1 Guangzhou Hanfang Pharmaceutical Co., Ltd. Company Information
7.7.2 Guangzhou Hanfang Pharmaceutical Co., Ltd. Introduction and Business Overview
7.7.3 Guangzhou Hanfang Pharmaceutical Co., Ltd. Hyoscine Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Guangzhou Hanfang Pharmaceutical Co., Ltd. Hyoscine Product Offerings
7.7.5 Guangzhou Hanfang Pharmaceutical Co., Ltd. Recent Development
7.8 Myungmoon Pharma Co., Ltd.
7.8.1 Myungmoon Pharma Co., Ltd. Company Information
7.8.2 Myungmoon Pharma Co., Ltd. Introduction and Business Overview
7.8.3 Myungmoon Pharma Co., Ltd. Hyoscine Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Myungmoon Pharma Co., Ltd. Hyoscine Product Offerings
7.8.5 Myungmoon Pharma Co., Ltd. Recent Development
7.9 Novartis International AG
7.9.1 Novartis International AG Company Information
7.9.2 Novartis International AG Introduction and Business Overview
7.9.3 Novartis International AG Hyoscine Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Novartis International AG Hyoscine Product Offerings
7.9.5 Novartis International AG Recent Development
7.10 Perrigo Company Plc
7.10.1 Perrigo Company Plc Company Information
7.10.2 Perrigo Company Plc Introduction and Business Overview
7.10.3 Perrigo Company Plc Hyoscine Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Perrigo Company Plc Hyoscine Product Offerings
7.10.5 Perrigo Company Plc Recent Development
7.11 Boehringer-Ingelheim
7.11.1 Boehringer-Ingelheim Company Information
7.11.2 Boehringer-Ingelheim Introduction and Business Overview
7.11.3 Boehringer-Ingelheim Hyoscine Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Boehringer-Ingelheim Hyoscine Product Offerings
7.11.5 Boehringer-Ingelheim Recent Development
7.12 Linnea
7.12.1 Linnea Company Information
7.12.2 Linnea Introduction and Business Overview
7.12.3 Linnea Hyoscine Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Linnea Hyoscine Product Offerings
7.12.5 Linnea Recent Development
7.13 C2 PHARMA
7.13.1 C2 PHARMA Company Information
7.13.2 C2 PHARMA Introduction and Business Overview
7.13.3 C2 PHARMA Hyoscine Sales, Revenue and Gross Margin (2019-2024)
7.13.4 C2 PHARMA Hyoscine Product Offerings
7.13.5 C2 PHARMA Recent Development
8 Industry Chain Analysis
8.1 Hyoscine Industrial Chain
8.2 Hyoscine Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Hyoscine Sales Model
8.5.2 Sales Channel
8.5.3 Hyoscine Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Alchem International Ltd.
Alkaloids Corporation
Baxter International Inc.
Caleb Pharmaceuticals, Inc.
Centroflora Cms S. R.L.
GlaxoSmithKline Plc
Guangzhou Hanfang Pharmaceutical Co., Ltd.
Myungmoon Pharma Co., Ltd.
Novartis International AG
Perrigo Company Plc
Boehringer-Ingelheim
Linnea
C2 PHARMA

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.